Tag Archive | "big biotech"

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

Tags: , , , ,


An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen

De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. Read the full story

Celgene acquires Quanticel Pharmaceuticals

Tags: , , ,


Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel Read the full story

MedImmune and Immunocore partner for melanoma combinations

Tags: , ,


Immunocore will conduct a Phase Ib/II clinical trial combining checkpoint inhibitors MEDI4736 (anti-PD-L1) and/or tremelimumab (anti-CTLA-4) with IMCgp100 Read the full story

Mesoblast banks $45mn financing from Celgene

Tags: , ,


Mesoblast has entered into an Agreement with Celgene Read the full story

Morphosys regains MOR202 rights from Celgene

Tags: , , , ,


MorphoSys has regained rights to MOR202 from Celgene Read the full story

Celgene and Zymeworks partner for bi-specific antibody therapeutics

Tags: , , ,


Zymeworks announced a collaboration and licensing agreement with Celgene for the research, development, and commercialization of bi-specific antibody therapeutics enabled using Zymeworks’ proprietary Azymetric platform Read the full story

Amgen biopharma partners for supporting startups

Tags: , ,


Amgen and LabCentral biopharma partners: announced an agreement in which Amgen has become a LabCentral platinum sponsor. Read the full story

Servier and GeNeuro in GNbAC1 multiple sclerosis deal

Tags: , ,


GeNeuro has entered into a strategic partnership with Servier to develop and market GNbAC1 in Multiple Sclerosis Read the full story

Modern Biosciences and Janssen Biotech partner for novel bone-protective compounds for RA

Tags: , , , ,


Modern Biosciences has entered into an R&D alliance and global option and licence agreement with Janssen Biotech in relation to MBS’ novel bone-protective compounds for the treatment of rheumatoid arthritis Read the full story

Janssen and Transposagen in CAR-T pact

Tags: , , ,


Transposagen Biopharmaceuticals have entered into a research collaboration and worldwide license agreement with Janssen Biotech to develop allogeneic Chimeric Antigen Receptor T-cells (CAR-T) Read the full story